₹8.39

▼ -0.17 -1.99%

29 Jul 2026

BSE Listed

GSM · GSM 0 · ESM · ESM 2

What does GSM · GSM 0 · ESM · ESM 2 mean?

BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).

BSE · Enhanced Surveillance Measure (ESM 2)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-15

Kobo Biotech Limited (531541)

Volume: 2,250Avg Vol 1W: 1,645Avg Vol 1M: 91,77452W Range:₹1.99₹9.99

BSE www.kobobiotech.com AI Report

Key Ratios

Checked just now

Market Cap₹20 Cr

Current Price₹8.39

Previous Close₹8.56

High / Low (52w)₹9.99 / ₹1.99

Volume2,250

Avg Vol (1W)1,645

Avg Vol (1M)91,774

Stock P/E—

Book Value₹-57.98

Dividend Yield0%

ROE370.84%

ROA-7.06%

Revenue (TTM)—

Revenue Growth—

Profit Margin0%

Total Debt—

Shares Outstanding2 Cr

Face Value—

EPS (TTM)₹0

P/B—

Debt / Equity3.38

50 DMA₹6.89

200 DMA₹3.59

Day change-1.99%

SurveillanceGSM · GSM 0 · ESM · ESM 2

Price Chart

₹8.39▲ 238.31% · 1Y

2025-07-29

2026-07-29

20-day avg volume: 85K shares

Pros

Healthy return on equity of 370.8%.
Company is almost debt-free.

Cons

Revenue fell 74% YoY.
Company is loss-making at the latest annual result.
Negative book value per share.

Quarterly Results

Metric	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
EBITDA	₹-1 Cr	₹-1 Cr	₹-2 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr
Net Profit	₹-1 Cr	₹-1 Cr	₹-2 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr	₹-1 Cr
EPS	—	—	—	—	—	—	—	—

Profit & Loss (Annual)

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015
Revenue	₹162 Cr	₹287 Cr	₹404 Cr	₹404 Cr	₹103 Cr
EBITDA	₹23 Cr	₹38 Cr	₹33 Cr	₹33 Cr	₹-10 Cr
Net Profit	₹10 Cr	₹15 Cr	₹14 Cr	₹14 Cr	₹-35 Cr
EPS	4.38	6.72	6.22	6.22	-15.47

Balance Sheet

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015
Total Assets	₹250 Cr	₹346 Cr	₹412 Cr	₹412 Cr	₹396 Cr
Total Liabilities	₹189 Cr	₹270 Cr	₹324 Cr	₹324 Cr	₹343 Cr
Equity	₹61 Cr	₹76 Cr	₹88 Cr	₹88 Cr	₹53 Cr
Total Debt	—	—	—	—	—

Cash Flow

Metric	Mar 2012	Mar 2013	Mar 2014	Mar 2015
Operating	₹66 Cr	₹39 Cr	₹39 Cr	₹7 Cr
Investing	₹-14 Cr	₹-7 Cr	₹-7 Cr	₹-5 Cr
Financing	₹-27 Cr	₹-38 Cr	₹-38 Cr	₹-13 Cr
Free Cash Flow	₹66 Cr	₹39 Cr	₹39 Cr	₹7 Cr

Shareholding

Promoter 44.95% Institutions 0% Public 55.05%

Efficiency & Working Capital

ROCE-72.7%

Interest Coverage-0.4

Dividend Payout—

Debtor Days666 d

Inventory Days267 d

Payable Days416 d

Cash Conversion Cycle517 d

Working Capital Days932 d

Shareholding Details

As of 2026-06-30

Promoter44.9%

FII0%

DII0%

Institutions0%

Public55.1%

Promoter Pledge0%

No. of Shareholders7,734

Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

Period	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%	44.9%
FIIs	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DIIs	0.7%	0.7%	0.7%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Public	54.4%	54.4%	54.4%	55.1%	55.1%	55.1%	55.1%	55.1%	55.1%	55.1%	55.1%	55.1%
Promoter Pledge	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
No. of Shareholders	6,478	6,530	6,767	6,788	6,916	7,542	7,873	7,929	7,947	7,970	7,977	7,734

Returns History (ROE / ROCE / ROA)

Period	ROE	ROCE	ROA	P/E
202503	—	—	—	—

Major Shareholders (>1%)

Name	Category	Stake	Shares
Arch Pharmalabs Ltd	Shareholding of Promoter and Promoter Group	45%	1.07 Cr
Sanjay Luthra	Public Shareholding	1.1%	2,51,861

Board of Directors

Name	Designation	Year
Ajit Kamath	Chairman (Non-Executive)	2022
Rajendra Kaimal	Non-Executive & Non-Independent Director	2022
Jignesh Patel	Company Sec. & Compli. Officer	2022
Sunil Pitroda	Non Executive & Independent Director	2022
Abhishek Buddhadev	Non Executive & Independent Director	2022
Urja Shah	Non Executive & Independent Director	2022

Segments — Geography

Region	Revenue	Share
Domestic	₹8 Cr	25.6%
Exports	₹24 Cr	74.4%

Capital Structure (₹ Cr)

Year	Face Value	Authorised	Issued	Paid-up
2025	₹10	40	24	24

Related-Party Transactions (₹ Cr)

Year	Others	Total
2023	53	53
2023	2	2
2023	51	51

More stocks

Desh Rakshak Aushdhalaya Ltd.Softrak Venture Investment Ltd.Accedere Limited Mizzen Ventures Limited Rishabh Digha Steel & Allied Products Ltd.Maruti Infrastructure Ltd.Somany Ceramics Jhaveri Credits & Capital Ltd.Raghunath Tobacco Co.Ltd.Disha Resources Limited Coral India Finance Amit Securities Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search